Results for tag: "Trametinib"

Trametinib is an oncology drug used to treat certain types of cancer, such as melanoma, non-small cell lung cancer, and metastatic colorectal cancer. It is a type of targeted therapy, meaning it works by targeting specific molecules involved in the growth and spread of cancer cells. Trametinib works by blocking the activity of a protein called MEK, which is involved in the growth and spread of cancer cells. It is usually taken as a pill once a day. Trametinib is approved by the US Food and Drug Administration (FDA) for the treatment of certain types of cancer. It is also approved in other countries, including the European Union, Canada, and Australia. The trametinib market is a rapidly growing segment of the oncology drug market. It is expected to continue to grow as more patients are diagnosed with cancer and as new treatments become available. Some companies in the trametinib market include Novartis, Merck, and AstraZeneca. Show Less Read more